The role of glutamate and its receptors in multiple sclerosis

Journal of Neural Transmission

Volumn 121, Issue 8, 2014, Pages 945-955

  Stojanovic, Ivana R ^a   Kostic, Milos ^a   Ljubisavljevic, Srdjan ^a  

^a UNIVERSITY OF NI   (Serbia)

Author keywords

Excitotoxicity; Glutamate; Multiple sclerosis; Neurodegeneration

Indexed keywords

CALCIUM; GLUTAMATE RECEPTOR; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; NITRIC OXIDE; REACTIVE NITROGEN SPECIES;

ARTICLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXCITOTOXICITY; HOMEOSTASIS; HUMAN; MULTIPLE SCLEROSIS; NERVE CELL DEGENERATION; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; ANIMAL; IMMUNOMODULATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; GLUTAMIC ACID; HUMANS; MULTIPLE SCLEROSIS; NEUROIMMUNOMODULATION; RECEPTORS, GLUTAMATE;

EID: 84925709307     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-014-1188-0     Document Type: Article

References (107)

1. Aarum J, Sandberg K, Haeberlein SL, Persson MA (2003) Migration and differentiation of neural precursor cells can be directed by microglia. Proc Natl Acad Sci USA 100:15983-15988
2. Abbott NJ (2000) Inflammatory mediators and modulation of bloodbrain barrier permeability. Cell Mol Neurobiol 20:131-147
3. Agulhon C, Fiacco TA, McCarthy KD (2010) Hippocampal shortand longterm plasticity are not modulated by astrocyte Ca2? signaling. Science 327:1250-1254
4. Alix JJ, Domingues AM (2011) White matter synapses: form, function, and dysfunction. Neurology 76:397-404
5. Allen M, Zou F, Chai HS, Younkin CS, Miles R, Nair AA, Crook JE, Pankratz VS, Carrasquillo MM, Rowley CN, Nguyen T, Ma L, Malphrus KG, Bisceglio G, Ortolaza AI, Palusak R, Middha S, Maharjan S, Georgescu C, Schultz D, Rakhshan F, Kolbert CP, Jen J, Sando SB, Aasly JO, Barcikowska M, Uitti RJ, Wszolek ZK, Ross OA, Petersen RC, Graff-Radford NR, Dickson DW, Younkin SG, Ertekin-Taner N (2012) Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-atdiagnosis and brain gene expression: an association study with mechanistic implications. Mol Neurodegener 7:13
6. Ames AI (2000) CNS energy metabolism as related to function. Brain Res Brain Res Rev 34:42-68
7. Bagasra O, Michaels FH, Zheng YM, Bobroski LE, Spitsin SV, Fu ZF (1995) Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci USA 92(26):12041-12045
8. Bender LM, Morgan MJ, Thomas LR, Liu ZG, Thorburn A (2005) The adaptor protein TRADD activates distinct mechanisms of apoptosis from the nucleus and the cytoplasm. Cell Death Differ 12:473-481
9. Block ML, Hong JS (2005) Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76(2):77-98
10. Bogaert L, Scheller D, Moonen J, Sarre S, Smolders I, Ebinger G, Michotte Y (2000) Neurochemical changes and laser Doppler flowmetry in the endothelin-1 rat model for focal cerebral ischemia. Brain Res 887:266-275
11. Bolton C, Paul C (2006) Glutamate receptors in neuroinflammatory demyelinating disease. Mediat Inflamm 2:93684
12. Brandon M, Baldi P, Wallace DC (2006) Mitochondrial mutations in cancer. Oncogene 25(34):4647-4662
13. Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, Bird ED, Beal MF (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 41:646-653
14. Burdo J, Dargusch R, Schubert D (2006) Distribution of the cystine/ glutamate antiporter system xc- in the brain, kidney, and duodenum. J Histochem Cytochem 54:549-557
15. Butovsky O, Landa G, Kunis G, Ziv Y, Avidan H, Greenberg N (2006) Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest 116:905-915
16. Centonze D, Muzio L, Rossi S, Cavasinni F, De Chiara V, Bergami A (2009) Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci 29:3442-3452
17. Centonze D, Muzio L, Rossi S, Furlan R, Bernardi G, Martino G (2010) The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis. Cell Death Differ 17:1083-1091
18. Choi IY, Lim JH, Kim C, Song HY, Ju C, Kim WK (2013) 4-Hydroxy-2(E)-nonenal facilitates NMDA-induced neurotoxicity via triggering mitochondrial permeability transition pore opening and mitochondrial calcium overload. Exp Neurobiol 22(3):200-207
19. Chung RS, McCormack GH, King AE, West AK, Vickers JK (2005) Glutamate induces rapid loss of axonal neurofilament proteins from cortical neurons in vitro. Exp Neurol 193:481-488
20. Cianfoni A, Niku S, Imbesi SG (2007) Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy. AJNR Am J Neuroradiol 28:272-277
21. Collard CD, Park KA, Montalto MC, Alapati S, Buras JA, Stahl GL, Colgan SP (2002) Neutrophil-derived glutamate regulates vascular endothelial barrier function. J Biol Chem 277:14801-14811
22. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65(1):1-105
23. Decoursey TE, Ligeti E (2005) Regulation and termination of NADPH oxidase activity. Cell Mol Life Sci 62(19-20): 2173-2193
24. Degos V, Peineau P, Kaindl AM, Sigaut S, Favrais G, Plaisant F, Teissier N, Gouadon E, Lombet A, Saliba E, Collingridge GL, Maze M, Nicoletti F, Heijnen C, Mantz J, Kavelaars A, Gressens P (2013) G protein-coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation-induced sensitization to excitotoxic neurodegeneration. Ann Neurol 73(5):667-678
25. Dempsey RJ, Baskaya MK, Dogan A (2000) Attenuation of brain edema, blood-brain barrier breakdown, and injury volume by ifenprodil, a polyamine-site N-methyl-D-aspartate receptor antagonist, after experimental traumatic brain injury in rats. Neurosurgery 47:399-404
26. Domercq M, Sá'nchez-Gómez MV, Sherwin C, Etxebarria E, Fern R, Matute C (2007) System xc - and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. J Immunol 178:6549-6556
27. Dutta R, McDonough J, Yin X, Peterson J, Chang A, Torres T, Gudz T, Maclin WB, Lewis DA, Fox RJ, Rudick R, Mirnics K, Trapp BD (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59(3):478-489
28. Fang J, Han D, Hong J, Tan Q, Tian Y (2012) The chemokine, macrophage inflammatory protein-2c, reduces the expression of glutamate transporter-1 on astrocytes and increases neuronal sensitivity to glutamate excitotoxicity. J Neuroinflammation 9:267
29. Farooqui T, Farooqui AA (2009) Aging: an important factor for the pathogenesis of neurodegenerative diseases. Mech Ageing Dev 130:203-215
30. Fiebiger SM, Bros H, Grobosch T, Janssen A, Chanvillard C, Paul F, Dörr J, Millward JM, Infante-Duarte C (2013) The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse. J Neuroimmunol 262:66-71
31. Floden AM, Li S, Combs CK (2005) Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors. J Neurosci 25:2566-2575
32. Forte M, Gold BG, Marracci G, Chaudhary P, Basso E, Johnsen D, Yu X, Fowlkes J, Rahder M, Stem K, Bernardi P, Bourdette D (2007) Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proc Natl Acad Sci USA 104:7558-7563
33. Frigo M, Cogo MG, Fusco ML, Gardinetti M, Frigeni B (2012) Glutamate and multiple sclerosis. Curr Med Chem 19(9):1295-1299
34. Gehrmann J, Banati RB (1995) Microglial turnover in the injured CNS: activated microglia undergo delayed DNA fragmentation following peripheral nerve injury. J Neuropathol Exp Neurol 54:680-688
35. Gray E, Rice C, Nightingale H, Ginty M, Hares K, Kemp K, Cohen N, Love S, Scolding N, Wilkins A (2013) Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis. Mult Scler J 19(2):153-161
36. Gurwitz D, Kloog Y (1998) Peroxynitrite generation might explain elevated glutamate and aspartate levels in multiple sclerosis cerebrospinal fluid. Eur J Clin Invest 28(9):760-761
37. Hauser DN, Cookson MR (2011) Astrocytes in Parkinson's disease and DJ-1. J Neurochem 117:357-358
38. Huang Y, Erdmann N, Peng H, Zhao Y, Zheng J (2005) The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases. Cell Mol Immunol 2:113-122
39. Imai F, Suzuki H, Oda J, Ninomiya T, Ono K, Sano H, Sawada M (2007) Neuroprotective effect of exogenous microglia in global brain ischemia. J Cereb Blood Flow Metab 27(3):488-500
40. Julio-Pieper M, Flor PJ, Dinan TG, Cryan JF (2011) Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues. Pharmacol Rev 63:35-58
41. Kaltsonoudis E, Voulgari PV, Konitsiotis S, Drosos AA (2014) Demyelination and other neurological adverse events after anti- TNF therapy. Autoimmun Rev 13:54-58
42. Kanai Y, Trotti D, Nussberger S, Hediger MA (1997) The high affinity glutamate transporter family: structure, function and physiological relevance. In: Reith MEA (ed) Neurotransmitter transporters: structure, function, and regulation. Humana Press, Totowa, NJ, pp 171-214
43. Kroemer G, Galluzzi L, Brenner C (2007) Mitochondrial membrane permeabilization in cell death. Physiol Rev 87(1):99-163
44. Kumar P, Kalonia H, Kumar A (2011) Role of LOX/COX pathways in 3-nitropropionic acid induced Huntington's disease-like symptoms in rats: protective effect of licofelone. Br J Pharmacol 164(2b):644-654
45. Kumar P, Kalonia H, Kumar A (2012) Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity. Eur J Pharmacol 674(2-3):265-274
46. Li JM, Fan LM, Christie MR, Shah AM (2005) Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4. Mol Cell Biol 25(6):2320-2330
47. Lim SY, Constantinescu CS (2010) TNF-a: a paradigm of paradox and complexity in multiple sclerosis and its animal models. Open Autoimmun J 2:160-170
48. Lipton SA (2008) NMDA receptor activity regulates transcription of antioxidant pathways. Nat Neurosci 11(4):381-382
49. Ljubisavljevic S, Stojanovic I, Pavlovic D, Milojkovic M, Pavlovic D, Vojinovic S, Sokolovic D, Stevanovic I (2012) Correlation of nitric oxide levels in the cerebellum and spinal cord of experimental autoimmune encephalomyelitis rats with clinical symptoms. Acta Neurobiol Exp (Wars) 72:33-39
50. Love S (1999) Oxidative stress in brain ischemia. Brain Pathol 9:119-131
51. Lu F, Selak M, O'Connor J, Croul S, Lorenzana C, Butunoi C, Kalman B (2000) Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 177:95-103
52. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707-717
53. Mahad D, Ziabreva I, Lassmann H, Turnbull D (2008) Mitochondrial defects in acute multiple sclerosis lesions. Brain 131:1722-1735
54. Mahad DJ, Ziabreva I, Campbell G, Lax N, White K, Hanson PS, Lassmann H, Turnbull DM (2009) Mitochondrial changes within axons in multiple sclerosis. Brain 132:1161-1174
55. Mahler A, Steiniger J, Bock M, Brandt AU, Haas V, Boschmann M, Paul F (2012) Is metabolic flexibility altered in multiple sclerosis patients? PLoS One 7(8):e43675
56. Maragakis NJ, Rothstein JD (2006) Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Prac Neurol 2:679-689
57. Martindale JL, Holbrook NJ (2002) Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192:1-15
58. Mattle HP, Lienert C, Greeve I (2004) Uric acid and multiple sclerosis [in German]. Ther Umsch 61(9):553-555
59. Matute C (2006) Oligodendrocyte NMDA receptors: a novel therapeutic target. Trends Mol Med 12:289-292
60. Mecocci P, MacGarvey U, Kaufman AE, Koontz D, Shoffner JM, Wallace DC, Beal MF (1993) Oxidative damage to mitochondrial DNA shows marked age dependent increases in human brain. Ann Neurol 34:609-616
61. Melzer N, Meuth SG, Torres-Salazar D, Bittner S, Zozulya AL, Weidenfeller C, Kotsiari A, Stangel M, Fahlke C, Wiendl H (2008) A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis. PLoS One 3:e3149
62. Neumann H (2001) Control of glial immune function by neurons. Glia 36(2):191-199
63. Newcombe J, Uddin A, Dove R, Patel B, Turski L, Nishizawa Y (2008) Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol 18:52-61
64. Newsholme EA, Calder PC (1997) The proposed role of glutamine in some cells of the immune system and speculative consequences for the whole animal. Nutrition 13(7-8):728-730
65. Nicholls DG (2004) Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures. Curr Mol Med 4:149-177
66. Norenberg MD, Rao KVR (2007) The mitochondrial permeability transition in neurologic disease. Neurochem Int 50(7-8):983-997
67. Ohgoh M, Hanada T, Smith T, Hashimoto T, Ueno M, Yamanishi Y, Watanabe M, Nishizawa Y (2002) Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis. J Neuroimmunol 125(1-2):170-178
68. Palmer GC (2001) Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies. Curr Drug Targets 2:241-271
69. Pampliega O, Domercq M, Soria FN, Villoslada P, Rodríguez- Antigüedad A, Matute CJ (2011) Increased expression of cystine/glutamate antiporter in multiple sclerosis. J Neuroinflammation 8:63
70. Perea G, Araque A (2010) Glia modulates synaptic transmission. Brain Res Rev 63(1-2):93-102
71. Piani D, Fontana A (1994) Involvement of the cystine transport system xc- in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J Immunol 152(7):3578-3585
72. Pinteaux-Jones F, Sevastou IG, Fry VA, Heales S, Baker D, Pocock JM (2008) Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors. J Neurochem 106(1):442-454
73. Pitt D, Werner P, Raine CS (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6:67-70
74. Rahn KA, Slusher BS, Kaplin AI (2012) Glutamate in CNS neurodegeneration and cognition and its regulation by GCPII inhibition. Curr Med Chem 19(9):1335-1345
75. Ribeiro FM, Paquet M, Cregan SP, Ferguson SS (2010) Group I metabotropic glutamate receptor signalling and its implication in neurological disease. CNS Neurol Disord Drug Targets 9:574-595
76. Rose JW, Hill KE, Watt HE, Carlson NG (2004) Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesion. J Neuroimmunol 149(1-2):40-49
77. Rossi S, Motta C, Studer V, Barbieri F, Buttari F, Bergami A, Sancesario G, Bernardini S, De Angelis G, Martino G, Furlan R, Centonze D (2014) Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration. Mult Scler 20(3):304-312. doi:10.1177/135245851 3498128
78. Sarchielli P, Greco L, Floridi A, Floridi A, Gallai V (2003) Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid. Arch Neurol 60:1082-1088
79. Sendrowski K, Rusak M, Sobaniec P, Iłendo E, Dąbrowska M, Boćkowski L, Koput A, Sobaniec W (2013) Study of the protective effect of calcium channel blockers against neuronal damage induced by glutamate in cultured hippocampal neurons. Pharmacol Rep 65(3):730-746
80. Sharp CD, Hines I, Houghton J, Warren A, Jackson TH, Jawahar A, Nanda A, Elrod JW, Long A, Chi A, Minagar A, Alexander JS (2003) Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor. Am J Physiol Heart Circ Physiol 285:H2592-H2598
81. Sinnecker T, Mittelstaedt P, Dörr J, Pfueller CF, Harms L, Niendorf T, Paul F, Wuerfel J (2012) Multiple sclerosis lesions and irreversible brain tissue damage a comparative ultrahigh-field strength magnetic resonance imaging study. Arch Neurol 69(6):739-745
82. Steinert JR, Chernova T, Forsythe ID (2010) Nitric oxide signaling in brain function, dysfunction, and dementia. Neuroscientist 16:435-452
83. Stojanovic I, Vojinovic S, Ljubisavljevic S, Pavlovic R, Basic J, Pavlovic D, Ilic A, Cvetkovic T, Stukalov M (2012) INF-b1b therapy modulates L-arginine and nitric oxide metabolism in patients with relapse remittens multiple sclerosis. J Neurol Sci 323(1-2):187-192
84. Sulkowski G, Dąbrowska-Bouta B, Chalimoniuk M, Strużyńska (2013) Effects of antagonists of glutamate receptors on proinflammatory cytokines in the brain cortex of rats subjected to experimental autoimmune encephalomyelitis. J Neuroimmunol 261(1-2):67-76
85. Takeuchi H, Jin S, Wang J, Zhang G, Kawanokuchi J, Kuno R, Sonobe Y, Mizuno T, Suzumura A (2006) Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem 281:21362-21368
86. Tilleux S, Hermans E (2007) Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neurosci Res 85:2059-2070
87. Tolosa L, Caraballo-Miralles V, Olmos G, Lladó J (2011) TNF-a potentiates glutamate-induced spinal cord motoneuron death via NF-jB. Mol Cell Neurosci 46(1):176-186
88. Trapp BD, Stys PK (2009) Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 8:280-291
89. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62:405-496
90. Vallejo-Illarramendi A, Domercq M, Pérez-Cerdá' F, Ravid R, Matute C (2006) Increased expression and function of glutamate transporters in multiple sclerosis. Neurobiol Dis 21:154-164
91. van Horssen J, Witte ME, Ciccarelli O (2012) The role of mitochondria in axonal degeneration and tissue repair in MS. Mult Scler J 18(8):1058-1067
92. van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, von Blomberg BM, Woody JN, Hartung HP, Polman CH (1996) Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47:1531-1534
93. Vercellino M, Merola A, Piacentino C, Votta B, Capello E, Mancardi GL (2007) Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J Neuropathol Exp Neurol 66:732-739
94. Verkhratsky A (2010) Physiology of neuronal-glial networking. Neurochem Int 57:332-343
95. Veto S, Acs P, Bauer J, Berente Z, Setalo G Jr, Borgulya G, Sumegi B, Komoly S, Gallyas F Jr, Illes Z (2010) Inhibiting poly(ADPribose) polymerase: a potential therapy against oligodendrocyte death. Brain 133(Pt 3):822-834
96. Virgili N, Mancera P, Wappenhans B, Sorrosal G, Biber K, Pugliese M, Espinosa-Parrilla JF (2013) KATP channel opener diazoxide prevents neurodegeneration: a new mechanism of action via antioxidative pathway activation. PLoS ONE 8(9):e75189
97. Walton NM, Sutter BM, Laywell ED, Levkoff LH, Kearns SM, Marshall GP 2nd, Scheffler B, Steindler DA (2006) Microglia instruct subventricular zone neurogenesis. Glia 54:815-825
98. West AR, Tseng KY (2011) Nitric oxide-soluble guanylyl cyclasecyclic GMP signaling in the striatum: new targets for the treatment of Parkinson's disease? Front Syst Neurosci 5:1-55
99. Willard SS, Koochekpour S (2013) Glutamate, glutamate receptors, and downstream signaling pathways. Int J Biol Sci 9(9):948-959
100. Witte ME, Bø L, Rodenburg RJ, Belien JA, Musters R, Hazes T, Wintjes LT, Smeitink JA, Geurts JJ, De Vries HE, van der Valk P, van Horssen J (2009) Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol 219(2):193-204
101. Witte ME, Geurts JJG, de Vries HE, van der Valk P, van Horssen J (2010) Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion 10:411-418
102. Witte ME, Nijland PG, Drexhage JAR, Gerritsen W, Geerts D, van het Hof B, de Reijerkerk A, Vries HE, van der Valk P, van Horssen J (2013) Reduced expression of PGC-1a partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex. Acta Neuropathol 125:231-243
103. Yacoubian TA, Slone SR, Harrington AJ, Hamamichi S, Schieltz JM, Caldwell KA (2010) Differential neuroprotective effects of 14-3- 3 proteins in models of Parkinson's disease. Cell Death Dis 1:e2
104. Yawata I, Takeuchi H, Doi Y, Liang J, Mizuno T, Suzumura A (2008) Macrophage-induced neurotoxicity is mediated by glutamate and attenuated by glutaminase inhibitors and gap junction inhibitors. Life Sci 82(21-22):1111-1116
105. Ye L, Huang Y, Zhao L, Li Y, Sun L, Zhou Y, Qian G, Zheng JC (2013) IL-1β and TNF-α induce neurotoxicity through glutamate production: a potential role of glutaminase. J Neurochem 125:897-908
106. Zhao X, Bausano B, Pike BR, Newcomb-Fernandez JK, Wang KK, Shohami E, Ringger NC, DeFord SM, Anderson DK, Hayes RL (2001) TNF-alpha stimulates caspase-3 activation and apoptotic cell death in primary septo-hippocampal cultures. J Neurosci Res 64(2):121-131
107. Zindler E, Zipp F (2010) Neuronal injury in chronic CNS inflammation. Best Pract Res Clin Anaesthesiol 24(4):551-562